newsfilter
← Latest News
GlobeNewswire·

Achilles Therapeutics Selects Netrality's 401 North Broad for United States Headquarters

PHILADELPHIA, March 01, 2022 (GLOBE NEWSWIRE) -- Netrality announced today that Achilles Therapeutics plc (NASDAQ:ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, has leased 7,243 SF of lab